文献速递物质与行为成瘾焦虑、强迫与应激相关障碍

急性皮质醇升高增加[11C]NOP-1A与痛敏肽受体的体内结合:研究应激与抗应激神经肽相互作用的新成像范式

Acute Elevations in Cortisol Increase the In Vivo Binding of [11C]NOP-1A to Nociceptin Receptors: A Novel Imaging Paradigm to Study the Interaction Between Stress- and Antistress-Regulating Neuropeptides.
PubMed 文献 · Biol Psychiatry · 2019-09-25

本研究在19名健康对照者中,用[11C]NOP-1A PET测量基线及静脉氢化可的松挑战后痛敏肽(NOP)受体结合。氢化可的松导致血浆皮质醇急性升高,各脑区[11C]NOP-1A总分布容积(VT)平均升高11%至16%,且氢化可的松诱导的ΔVT与基线VT在部分脑区呈显著负相关。结论提示皮质醇升高增加NOP受体可用性,可能反映对抗促肾上腺皮质激素释放因子/应激的代偿机制。

要点

  • 氢化可的松挑战后各脑区[11C]NOP-1A VT平均升高11%至16%。
  • 氢化可的松诱导的ΔVT与基线VT在部分脑区显著负相关。
  • 该范式可用于研究应激神经肽与NOP受体在成瘾中的相互作用。

核心结论

  • 氢化可的松给药增加NOP受体可用性。
  • 皮质醇升高引起的NOP增加可能反映大脑对抗促肾上腺皮质激素释放因子和/或应激的代偿机制。
  • 该[11C]NOP-1A与氢化可的松成像范式可用于检查成瘾障碍中应激促进神经肽与NOP的相互作用。

研究设计与样本

  • 在19名健康对照者中,采用[11C]NOP-1A正电子发射断层扫描测量基线(BASE)和静脉氢化可的松挑战(CORT)后NOP受体结合。
  • 使用两组织室动力学分析测量11个感兴趣区的[11C]NOP-1A总分布容积(VT)。
  • 主要结局指标为氢化可的松诱导的ΔVT,计算为(VT CORT - VT BASE)/VT BASE。

主要发现

  • 氢化可的松导致血浆皮质醇水平急性升高。
  • 与基线相比,氢化可的松后各脑区[11C]NOP-1A VT平均升高11%至16%(线性混合模型,条件p = .005;脑区p < .001;条件×脑区p < .001)。
  • 所有感兴趣区的独立样本t检验均具有统计学意义,且通过多重比较校正。
  • 氢化可的松诱导的ΔVT与基线VT在多个感兴趣区呈显著负相关。

临床怎么用

  • 该成像范式可用于在活体人脑中间接考察皮质醇升高对NOP受体可用性的影响。
  • 结果提示皮质醇急性升高时NOP受体结合增加,可能作为应激代偿通路的生物标志物用于成瘾研究。

局限性

  • 研究仅纳入19名健康对照者,未涉及成瘾障碍患者。
  • 氢化可的松挑战通过微透析研究推测可增加杏仁核等脑区促肾上腺皮质激素释放因子释放,但本研究未直接测量该释放。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An imbalance between neuropeptides that promote stress and resilience, such as corticotropin-releasing factor and nociceptin, has been postulated to underlie relapse in addiction. The objective of this study was to develop a paradigm to image the in vivo interaction between stress-promoting neuropeptides and nociceptin (NOP) receptors in humans. METHODS: [11C]NOP-1A positron emission tomography was used to measure the binding to NOP receptors at baseline (BASE) and following an intravenous hydrocortisone challenge (CORT) in 19 healthy control subjects. Hydrocortisone was used as a challenge because in microdialysis studies it has been shown to increase corticotropin-releasing factor release in extrahypothalamic brain regions such as the amygdala. [11C]NOP-1A total distribution volume (VT) in 11 regions of interest were measured using a 2-tissue compartment kinetic analysis. The primary outcome measure was hydrocortisone-induced ΔVT calculated as (VT CORT - VT BASE)/VT BASE. RESULTS: Hydrocortisone led to an acute increase in plasma cortisol levels. Regional [11C]NOP-1A VT was on average 11% to 16% higher in the post-hydrocortisone condition compared with the baseline condition (linear mixed model, condition, p = .005; region, p < .001; condition × region, p < .001). Independent Student's t tests in all regions of interest were statistically significant and survived multiple comparison correction. Hydrocortisone-induced ΔVT was significantly negatively correlated with baseline VT in several regions of interest. CONCLUSIONS: Hydrocortisone administration increases NOP receptor availability. Increased NOP in response to elevated cortisol might suggest a compensatory mechanism in the brain to counteract corticotropin-releasing factor and/or stress. The [11C]NOP-1A and hydrocortisone imaging paradigm should allow for the examination of interactions between stress-promoting neuropeptides and NOP in addictive disorders.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Flanigan M, Tollefson S, Himes ML, et al. Acute Elevations in Cortisol Increase the In Vivo Binding of [11C]NOP-1A to Nociceptin Receptors: A Novel Imaging Paradigm to Study the Interaction Between Stress- and Antistress-Regulating Neuropeptides. Biol Psychiatry. 2019. PMID: 31706582. doi:10.1016/j.biopsych.2019.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。